Smriti Agarwal1,2,3, Elizabeth Highton-Williamson4,5, Jashelle Caga4,5, José M Matamala4,5, Thanuja Dharmadasa4,5, James Howells4,5, Margaret C Zoing4,5, Kazumoto Shibuya4,5, Nimeshan Geevasinga6, Steve Vucic6, John R Hodges4, Rebekah M Ahmed4,5, Matthew C Kiernan4,5. 1. Brain and Mind Centre, Sydney Medical School, University of Sydney, Sydney, NSW, 2050, Australia. smriti.agarwal@cantab.net. 2. Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, 2050, Australia. smriti.agarwal@cantab.net. 3. Neurology Unit, Addenbrooke's Hospital, Cambridge, UK. smriti.agarwal@cantab.net. 4. Brain and Mind Centre, Sydney Medical School, University of Sydney, Sydney, NSW, 2050, Australia. 5. Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, 2050, Australia. 6. Westmead Clinical School, University of Sydney, Sydney, NSW, Australia.
Abstract
AIM: To investigate whether primary lateral sclerosis (PLS) represents part of the amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) spectrum of diseases. METHODS: Comprehensive assessment was taken on 21 patients with PLS and results were compared to patients diagnosed with pure motor ALS (n = 27) and ALS-FTD (n = 12). Clinical features, Addenbrooke's Cognitive Examination (ACE) scores, Motor Neuron Disease Behaviour (Mind-B) scores, motor disability on the ALS functional rating scale (ALSFRS) and survival times were documented. Motor cortex excitability was evaluated using transcranial magnetic stimulation (TMS). RESULTS: Global cognition was impaired in PLS (mean total ACE score 82.5 ± 13.6), similar to ALS-FTD (mean total ACE score 76.3 ± 7.7, p > 0.05) while behavioural impairments were not prominent. TMS revealed that resting motor threshold (RMT) was significantly higher in PLS (75.5 ± 6.2) compared ALS-FTD (50.1 ± 7.2, p < 0.001) and ALS (62.3 ± 12.6, p = 0.046). Average short-interval intracortical inhibition (SICI) was similar in all three patient groups. The mean survival time was longest in PLS (217.4 ± 22.4 months) and shortest in ALS-FTD (38.5 ± 4.5 months, p = 0.002). Bulbar onset disease (β = - 0.45, p = 0.007) and RMT (β = 0.54, p = 0.001) were independent predictors of global cognition while motor scores (β = 0.47, p = 0.036) and SICI (β = 0.58, p = 0.006) were significantly associated with ALSFRS. CONCLUSION: The cognitive profile in PLS resembles ALS-FTD, without prominent behavioural disturbances. A higher RMT in PLS than ALS and ALS-FTD is consistent with differential cortical motor neuronal abnormalities and more severe involvement of corticospinal axons while SICI, indicative of inhibitory interneuronal dysfunction was comparable with ALS and ALS-FTD. Overall, while these findings support the notion that PLS lies on the ALS-FTD spectrum, the mechanisms underlying slow disease progression are likely to be distinct in PLS.
AIM: To investigate whether primary lateral sclerosis (PLS) represents part of the amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) spectrum of diseases. METHODS: Comprehensive assessment was taken on 21 patients with PLS and results were compared to patients diagnosed with pure motor ALS (n = 27) and ALS-FTD (n = 12). Clinical features, Addenbrooke's Cognitive Examination (ACE) scores, Motor Neuron Disease Behaviour (Mind-B) scores, motor disability on the ALS functional rating scale (ALSFRS) and survival times were documented. Motor cortex excitability was evaluated using transcranial magnetic stimulation (TMS). RESULTS: Global cognition was impaired in PLS (mean total ACE score 82.5 ± 13.6), similar to ALS-FTD (mean total ACE score 76.3 ± 7.7, p > 0.05) while behavioural impairments were not prominent. TMS revealed that resting motor threshold (RMT) was significantly higher in PLS (75.5 ± 6.2) compared ALS-FTD (50.1 ± 7.2, p < 0.001) and ALS (62.3 ± 12.6, p = 0.046). Average short-interval intracortical inhibition (SICI) was similar in all three patient groups. The mean survival time was longest in PLS (217.4 ± 22.4 months) and shortest in ALS-FTD (38.5 ± 4.5 months, p = 0.002). Bulbar onset disease (β = - 0.45, p = 0.007) and RMT (β = 0.54, p = 0.001) were independent predictors of global cognition while motor scores (β = 0.47, p = 0.036) and SICI (β = 0.58, p = 0.006) were significantly associated with ALSFRS. CONCLUSION: The cognitive profile in PLS resembles ALS-FTD, without prominent behavioural disturbances. A higher RMT in PLS than ALS and ALS-FTD is consistent with differential cortical motor neuronal abnormalities and more severe involvement of corticospinal axons while SICI, indicative of inhibitory interneuronal dysfunction was comparable with ALS and ALS-FTD. Overall, while these findings support the notion that PLS lies on the ALS-FTD spectrum, the mechanisms underlying slow disease progression are likely to be distinct in PLS.
Entities:
Keywords:
ALS–FTD spectrum; Clinical; Cognitive; Motor cortical function; PLS; TMS
Authors: Parvathi Menon; Nimeshan Geevasinga; Con Yiannikas; James Howells; Matthew C Kiernan; Steve Vucic Journal: Lancet Neurol Date: 2015-04-03 Impact factor: 44.182
Authors: N Geevasinga; P Menon; C M Sue; K R Kumar; K Ng; C Yiannikas; M C Kiernan; S Vucic Journal: Eur J Neurol Date: 2015-02-12 Impact factor: 6.089
Authors: Sharpley Hsieh; Jashelle Caga; Felicity V C Leslie; Marlene Shibata; Naomi Daveson; David Foxe; Eleanor Ramsey; Patricia Lillo; Rebekah M Ahmed; Emma Devenney; James R Burrell; John R Hodges; Matthew C Kiernan; Eneida Mioshi Journal: J Geriatr Psychiatry Neurol Date: 2015-08-06 Impact factor: 2.680
Authors: Jennifer A Saxon; Jennifer C Thompson; Matthew Jones; Jennifer M Harris; Anna Mt Richardson; Tobias Langheinrich; David Neary; David Ma Mann; Julie S Snowden Journal: J Neurol Neurosurg Psychiatry Date: 2017-06-08 Impact factor: 10.154
Authors: Eoin Finegan; Stacey Li Hi Shing; Rangariroyashe H Chipika; Kai Ming Chang; Mary Clare McKenna; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Niall Pender; Colette Donaghy; Siobhan Hutchinson; Russell L McLaughlin; Orla Hardiman; Peter Bede Journal: Brain Imaging Behav Date: 2021-01-07 Impact factor: 3.978
Authors: Mehdi A J van den Bos; Nimeshan Geevasinga; Mana Higashihara; Parvathi Menon; Steve Vucic Journal: Int J Mol Sci Date: 2019-06-10 Impact factor: 5.923
Authors: Martin R Turner; Richard J Barohn; Philippe Corcia; John K Fink; Matthew B Harms; Matthew C Kiernan; John Ravits; Vincenzo Silani; Zachary Simmons; Jeffrey Statland; Leonard H van den Berg; Hiroshi Mitsumoto Journal: J Neurol Neurosurg Psychiatry Date: 2020-02-06 Impact factor: 10.154
Authors: Smriti Agarwal; Elizabeth Highton-Williamson; Jashelle Caga; James Howells; Thanuja Dharmadasa; José M Matamala; Yan Ma; Kazumoto Shibuya; John R Hodges; Rebekah M Ahmed; Steve Vucic; Matthew C Kiernan Journal: Sci Rep Date: 2021-01-26 Impact factor: 4.996